ZURA BIO LIMITED Stock Issued
ZURA BIO LIMITED (ZURA) reported Stock Issued of $6.23 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2026-03-19
- ZURA BIO LIMITED stock issued for the quarter ending 2024-12-31 was $0.00.
- ZURA BIO LIMITED stock issued for fiscal 2024 was $6.23M.
| Period end | Stock Issued 2 month | Stock Issued 3 month | Stock Issued 5 month | Stock Issued 8 month | Stock Issued 9 month | Stock Issued 11 month | Stock Issued 12 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $6.23M 10-K · filed 2026-03-19 | |||||
| 2024-09-30 | $6.23M 10-Q · filed 2025-11-13 | ||||||
| 2022-12-31 | $2.50M 10-K · filed 2024-03-28 | ||||||
| 2022-09-30 | $2.50M 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | $2.50M 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | $2.50M 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |